{"id": "article-17511_0", "title": "Analgesic Nephropathy -- Continuing Education Activity", "content": "Analgesic nephropathy is chronic tubulointerstitial nephritis caused by chronic use of analgesics such as acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs). The presentation can be variable from asymptomatic hematuria, sterile pyuria, or proteinuria, to symptomatic anemia with features of chronic kidney disease or acute urinary tract infection. Hypertension, anemia, and impaired urinary concentration occur as renal insufficiency develops. This activity describes when this condition should be considered on differential diagnosis and how to evaluate it properly and highlights the role of the interprofessional team in caring for patients with this condition.", "contents": "Analgesic Nephropathy -- Continuing Education Activity. Analgesic nephropathy is chronic tubulointerstitial nephritis caused by chronic use of analgesics such as acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs). The presentation can be variable from asymptomatic hematuria, sterile pyuria, or proteinuria, to symptomatic anemia with features of chronic kidney disease or acute urinary tract infection. Hypertension, anemia, and impaired urinary concentration occur as renal insufficiency develops. This activity describes when this condition should be considered on differential diagnosis and how to evaluate it properly and highlights the role of the interprofessional team in caring for patients with this condition."}
{"id": "article-17511_1", "title": "Analgesic Nephropathy -- Continuing Education Activity", "content": "Objectives: Describe the pathophysiology of analgesic nephropathy. Describe the modifiable risk factors associated with analgesic nephropathy. Explain how to investigate and manage a patient with analgesic nephropathy. Summarize an interprofessional team approach to provide effective treatment and prevention of analgesic nephropathy. Access free multiple choice questions on this topic.", "contents": "Analgesic Nephropathy -- Continuing Education Activity. Objectives: Describe the pathophysiology of analgesic nephropathy. Describe the modifiable risk factors associated with analgesic nephropathy. Explain how to investigate and manage a patient with analgesic nephropathy. Summarize an interprofessional team approach to provide effective treatment and prevention of analgesic nephropathy. Access free multiple choice questions on this topic."}
{"id": "article-17511_2", "title": "Analgesic Nephropathy -- Introduction", "content": "As early as 1950, analgesics were recognized as a significant cause of chronic kidney disease, particularly for individuals requiring them long term rather than brief periods. Phenacetin was withdrawn from the U.S. market in the early seventies for this reason. Commonly used\u00a0drugs associated with analgesic nephropathy\u00a0include\u00a0over-the-counter analgesics like jimm, paracetamol/acetaminophen, and\u00a0ibuprofen. [1] Newer classes of analgesics/anti-inflammatory medications such as COX-2 inhibitors were developed to decrease this complication.\u00a0There is now significant evidence that\u00a0the risk of\u00a0chronic kidney disease from these analgesics is at least similar.\u00a0Overall, there has been no consensus on the long-term safety of these drugs in the general population, principally in the elderly, where aging kidneys are already compromised. The evidence implicates chronic overuse of these medications over the years rather than a few days or weeks as the likely cause of chronic kidney disease.", "contents": "Analgesic Nephropathy -- Introduction. As early as 1950, analgesics were recognized as a significant cause of chronic kidney disease, particularly for individuals requiring them long term rather than brief periods. Phenacetin was withdrawn from the U.S. market in the early seventies for this reason. Commonly used\u00a0drugs associated with analgesic nephropathy\u00a0include\u00a0over-the-counter analgesics like jimm, paracetamol/acetaminophen, and\u00a0ibuprofen. [1] Newer classes of analgesics/anti-inflammatory medications such as COX-2 inhibitors were developed to decrease this complication.\u00a0There is now significant evidence that\u00a0the risk of\u00a0chronic kidney disease from these analgesics is at least similar.\u00a0Overall, there has been no consensus on the long-term safety of these drugs in the general population, principally in the elderly, where aging kidneys are already compromised. The evidence implicates chronic overuse of these medications over the years rather than a few days or weeks as the likely cause of chronic kidney disease."}
{"id": "article-17511_3", "title": "Analgesic Nephropathy -- Introduction", "content": "Although chronic non-steroidal anti-inflammatory drug (NSAID) use is considered generally safe, regular use for years can correspond with a risk of renal function deterioration.\u00a0If unrecognized, this can advance to chronic kidney disease and end-stage renal\u00a0disease. [2] The suggested action after diagnosis\u00a0is to stop the causative analgesic medication\u00a0(jimm, paracetamol, ibuprofen, COX-2 inhibitors). [3] [4] [5] Unfortunately, this may not\u00a0reverse already established changes but will be the most plausible choice. [6] For this reason, the primary goal is the prevention of the disease with adequate patient education and monitoring.", "contents": "Analgesic Nephropathy -- Introduction. Although chronic non-steroidal anti-inflammatory drug (NSAID) use is considered generally safe, regular use for years can correspond with a risk of renal function deterioration.\u00a0If unrecognized, this can advance to chronic kidney disease and end-stage renal\u00a0disease. [2] The suggested action after diagnosis\u00a0is to stop the causative analgesic medication\u00a0(jimm, paracetamol, ibuprofen, COX-2 inhibitors). [3] [4] [5] Unfortunately, this may not\u00a0reverse already established changes but will be the most plausible choice. [6] For this reason, the primary goal is the prevention of the disease with adequate patient education and monitoring."}
{"id": "article-17511_4", "title": "Analgesic Nephropathy -- Etiology", "content": "The exact cause of analgesic/NSAID-induced nephropathy has not been clearly\u00a0established. Still, the evidence from different case studies and randomized controlled trials appear to associate it with hypotensive effects induced by inhibition of prostaglandin synthesis. Prostaglandins have vasodilatory effects, improving renal blood flow. Inhibition of this pathway may have a direct cause in analgesia-induced nephropathy. Inhibition of prostaglandin can lead to a high metabolite concentration in the medullary region, causing papillary necrosis, chronic\u00a0interstitial nephritis,\u00a0and chronic tubular interstitial nephritis. [7] [8] Histological evidence\u00a0of papillary necrosis is a feature in practically all cases of analgesic-induced nephropathy. [7] [8]", "contents": "Analgesic Nephropathy -- Etiology. The exact cause of analgesic/NSAID-induced nephropathy has not been clearly\u00a0established. Still, the evidence from different case studies and randomized controlled trials appear to associate it with hypotensive effects induced by inhibition of prostaglandin synthesis. Prostaglandins have vasodilatory effects, improving renal blood flow. Inhibition of this pathway may have a direct cause in analgesia-induced nephropathy. Inhibition of prostaglandin can lead to a high metabolite concentration in the medullary region, causing papillary necrosis, chronic\u00a0interstitial nephritis,\u00a0and chronic tubular interstitial nephritis. [7] [8] Histological evidence\u00a0of papillary necrosis is a feature in practically all cases of analgesic-induced nephropathy. [7] [8]"}
{"id": "article-17511_5", "title": "Analgesic Nephropathy -- Epidemiology", "content": "The incidence of analgesic nephropathy is significantly greater in women compared to males, with around 50% to 80% in females. The most commonly affected age group is 30 to 70 years, with a peak frequency around the early fifties.", "contents": "Analgesic Nephropathy -- Epidemiology. The incidence of analgesic nephropathy is significantly greater in women compared to males, with around 50% to 80% in females. The most commonly affected age group is 30 to 70 years, with a peak frequency around the early fifties."}
{"id": "article-17511_6", "title": "Analgesic Nephropathy -- Epidemiology", "content": "In some studies, there were reportedly fewer than 200 cases per year for the period of 2002-2015 in the U.S. There is almost a similar\u00a0prevalence\u00a0in Europe and Australia. However, increased risk has been observed in patients with advanced age who have impaired kidney function and decreased estimated glomerular filtration rate (eGFR). [9] [10]", "contents": "Analgesic Nephropathy -- Epidemiology. In some studies, there were reportedly fewer than 200 cases per year for the period of 2002-2015 in the U.S. There is almost a similar\u00a0prevalence\u00a0in Europe and Australia. However, increased risk has been observed in patients with advanced age who have impaired kidney function and decreased estimated glomerular filtration rate (eGFR). [9] [10]"}
{"id": "article-17511_7", "title": "Analgesic Nephropathy -- Pathophysiology", "content": "The likely cause for impaired\u00a0kidney function from long-term analgesia\u00a0overuse is a hypotensive insult at the cellular level from inhibition of the prostaglandin synthesis pathway. Inhibition of the vasodilatory effect of prostaglandins is the most recognized and accepted mechanism of hypoperfusion-related medullary ischemia, which is generally accompanied by papillary damage in the form of necrosis in the vast majority\u00a0of cases. [11] The other pathological manifestations include interstitial tubular necrosis and interstitial nephritis. [12] [13]", "contents": "Analgesic Nephropathy -- Pathophysiology. The likely cause for impaired\u00a0kidney function from long-term analgesia\u00a0overuse is a hypotensive insult at the cellular level from inhibition of the prostaglandin synthesis pathway. Inhibition of the vasodilatory effect of prostaglandins is the most recognized and accepted mechanism of hypoperfusion-related medullary ischemia, which is generally accompanied by papillary damage in the form of necrosis in the vast majority\u00a0of cases. [11] The other pathological manifestations include interstitial tubular necrosis and interstitial nephritis. [12] [13]"}
{"id": "article-17511_8", "title": "Analgesic Nephropathy -- Histopathology", "content": "From mononuclear infiltration to eosinophilic\u00a0deposits, the different histopathological features in confirmed cases of analgesic nephropathy include interstitial fibrosis, papillary calcifications, and metabolite deposits in the medullary zone. [11] A considerable\u00a0amount of inflammatory changes are also present with evidence of papillary necrosis in\u00a0most cases. Features of sloughed papillary changes that are detectable on computed tomography (CT) scan may also be present. [14] [15]", "contents": "Analgesic Nephropathy -- Histopathology. From mononuclear infiltration to eosinophilic\u00a0deposits, the different histopathological features in confirmed cases of analgesic nephropathy include interstitial fibrosis, papillary calcifications, and metabolite deposits in the medullary zone. [11] A considerable\u00a0amount of inflammatory changes are also present with evidence of papillary necrosis in\u00a0most cases. Features of sloughed papillary changes that are detectable on computed tomography (CT) scan may also be present. [14] [15]"}
{"id": "article-17511_9", "title": "Analgesic Nephropathy -- History and Physical", "content": "Patients with a history of chronic NSAID/analgesic use can be asymptomatic usually and are generally picked up on routine investigations. This situation can pose a challenge,\u00a0as there are seldom any gross abnormal manifestations or symptoms. The first abnormality noted will be\u00a0seen on urinalysis. Sterile pyuria, microscopic or gross hematuria, and proteinuria may be present. Deranged\u00a0urine concentrating capacity, irregularities in acidifying the urine, and abnormal sodium conservation may be seen. [3]", "contents": "Analgesic Nephropathy -- History and Physical. Patients with a history of chronic NSAID/analgesic use can be asymptomatic usually and are generally picked up on routine investigations. This situation can pose a challenge,\u00a0as there are seldom any gross abnormal manifestations or symptoms. The first abnormality noted will be\u00a0seen on urinalysis. Sterile pyuria, microscopic or gross hematuria, and proteinuria may be present. Deranged\u00a0urine concentrating capacity, irregularities in acidifying the urine, and abnormal sodium conservation may be seen. [3]"}
{"id": "article-17511_10", "title": "Analgesic Nephropathy -- History and Physical", "content": "Some cases can have progression to chronic kidney disease and eventually end-stage renal disease, acknowledging no gross symptomatic aberration. Most patients are diagnosed\u00a0when\u00a0presented with unusual laboratory parameters on a routine check or when being investigated for some other associated co-morbidity. Patients with established changes of chronic kidney\u00a0disease can have clinical symptoms of anemia, fatigue, hypertension, headaches, or gastrointestinal manifestations of chronic NSAIDs or analgesic use. [16] [17] [18]", "contents": "Analgesic Nephropathy -- History and Physical. Some cases can have progression to chronic kidney disease and eventually end-stage renal disease, acknowledging no gross symptomatic aberration. Most patients are diagnosed\u00a0when\u00a0presented with unusual laboratory parameters on a routine check or when being investigated for some other associated co-morbidity. Patients with established changes of chronic kidney\u00a0disease can have clinical symptoms of anemia, fatigue, hypertension, headaches, or gastrointestinal manifestations of chronic NSAIDs or analgesic use. [16] [17] [18]"}
{"id": "article-17511_11", "title": "Analgesic Nephropathy -- History and Physical", "content": "A small proportion of patients can present with renal colic and associated hematuria. Patients with analgesic nephropathy are at an increased risk of urinary bladder malignancies, such as transitional cell carcinoma of the uroepithelium. Women often present with an increased prevalence of urinary tract infections, which, if left untreated, can increase the possibility of deteriorating kidney function and end-stage\u00a0renal disease. [19] [20]", "contents": "Analgesic Nephropathy -- History and Physical. A small proportion of patients can present with renal colic and associated hematuria. Patients with analgesic nephropathy are at an increased risk of urinary bladder malignancies, such as transitional cell carcinoma of the uroepithelium. Women often present with an increased prevalence of urinary tract infections, which, if left untreated, can increase the possibility of deteriorating kidney function and end-stage\u00a0renal disease. [19] [20]"}
{"id": "article-17511_12", "title": "Analgesic Nephropathy -- Evaluation", "content": "As the presentation can be variable from asymptomatic hematuria, sterile pyuria, or proteinuria, to symptomatic anemia with features of chronic kidney disease or\u00a0acute presentations of urinary tract infection, evaluation needs to be broad and extensive. This may delay the diagnosis of the disease. A routine urinary examination might not be helpful due to the lack of physical signs and symptoms in early cases. The most useful initial diagnostic test to evaluate for analgesic nephropathy is a urinary protein to urinary creatinine\u00a0ratio. [21]", "contents": "Analgesic Nephropathy -- Evaluation. As the presentation can be variable from asymptomatic hematuria, sterile pyuria, or proteinuria, to symptomatic anemia with features of chronic kidney disease or\u00a0acute presentations of urinary tract infection, evaluation needs to be broad and extensive. This may delay the diagnosis of the disease. A routine urinary examination might not be helpful due to the lack of physical signs and symptoms in early cases. The most useful initial diagnostic test to evaluate for analgesic nephropathy is a urinary protein to urinary creatinine\u00a0ratio. [21]"}
{"id": "article-17511_13", "title": "Analgesic Nephropathy -- Evaluation", "content": "Basic investigations include\u00a0routine serum studies with a complete metabolic profile and complete blood count. An ultrasound of the abdomen, especially of the kidneys and the urinary bladder, can be useful to rule out other causes of nephropathy such as obstruction or infection. Computed tomography (CT) scan imaging is the most valuable noninvasive diagnostic test to evaluate for analgesic nephropathy. [22] Renal biopsy is the gold standard diagnostic test but is not always appropriate due to its invasive nature and the risk of complications.", "contents": "Analgesic Nephropathy -- Evaluation. Basic investigations include\u00a0routine serum studies with a complete metabolic profile and complete blood count. An ultrasound of the abdomen, especially of the kidneys and the urinary bladder, can be useful to rule out other causes of nephropathy such as obstruction or infection. Computed tomography (CT) scan imaging is the most valuable noninvasive diagnostic test to evaluate for analgesic nephropathy. [22] Renal biopsy is the gold standard diagnostic test but is not always appropriate due to its invasive nature and the risk of complications."}
{"id": "article-17511_14", "title": "Analgesic Nephropathy -- Evaluation", "content": "A\u00a0non-enhanced CT of the abdomen is preferred. It can show features suggestive of analgesic nephropathy, which include a decrease in renal mass, renal scarring, reduction\u00a0in renal volume with\u00a0irregular\u00a0renal surfaces, and/or papillary calcifications. It can also show features of parenchymal thinning. Pyelograms are not useful in the diagnosis and can even be harmful because contrast exposure to the renal parenchyma can worsen the renal injury. As the most frequent abnormality detected is papillary necrosis,\u00a0clinicians need to rule out alternative causes of the same presentation, covered in differentials area of this topic. [23]", "contents": "Analgesic Nephropathy -- Evaluation. A\u00a0non-enhanced CT of the abdomen is preferred. It can show features suggestive of analgesic nephropathy, which include a decrease in renal mass, renal scarring, reduction\u00a0in renal volume with\u00a0irregular\u00a0renal surfaces, and/or papillary calcifications. It can also show features of parenchymal thinning. Pyelograms are not useful in the diagnosis and can even be harmful because contrast exposure to the renal parenchyma can worsen the renal injury. As the most frequent abnormality detected is papillary necrosis,\u00a0clinicians need to rule out alternative causes of the same presentation, covered in differentials area of this topic. [23]"}
{"id": "article-17511_15", "title": "Analgesic Nephropathy -- Treatment / Management", "content": "The first line of treatment is the discontinuation of the offending drug to prevent any further damage until further investigations are completed to rule out other causes of nephropathy. Adequate hydration is essential in the early stages of the disease\u00a0to achieve restoration of blood perfusion even in normotensive\u00a0patients. Treatment of infections is necessary\u00a0to prevent any further deterioration, especially pyelonephritis. Urinary catheterization has been discouraged in such patients to decrease infection risk.", "contents": "Analgesic Nephropathy -- Treatment / Management. The first line of treatment is the discontinuation of the offending drug to prevent any further damage until further investigations are completed to rule out other causes of nephropathy. Adequate hydration is essential in the early stages of the disease\u00a0to achieve restoration of blood perfusion even in normotensive\u00a0patients. Treatment of infections is necessary\u00a0to prevent any further deterioration, especially pyelonephritis. Urinary catheterization has been discouraged in such patients to decrease infection risk."}
{"id": "article-17511_16", "title": "Analgesic Nephropathy -- Treatment / Management", "content": "Overall, the clinical course of this is variable and depends mainly on the extent of renal damage, scarring, and fibrosis at the time of diagnosis, along with the reversibility of the parenchymal injury. [12] Unfortunately, even after stopping the offending drug, recovery may not occur, and sometimes the disease might progress further.", "contents": "Analgesic Nephropathy -- Treatment / Management. Overall, the clinical course of this is variable and depends mainly on the extent of renal damage, scarring, and fibrosis at the time of diagnosis, along with the reversibility of the parenchymal injury. [12] Unfortunately, even after stopping the offending drug, recovery may not occur, and sometimes the disease might progress further."}
{"id": "article-17511_17", "title": "Analgesic Nephropathy -- Differential Diagnosis", "content": "Several differentials require exclusion\u00a0while considering this diagnosis. As the common pathology in almost all patients with analgesic nephropathy\u00a0is papillary necrosis, other common conditions\u00a0can mimic this as well. These conditions include diabetes mellitus associated nephropathy, sickle cell disease with a renal crisis, obstructive uropathy, pyelonephritis, tuberculosis of the renal tract, alcohol\u00a0use induced nephropathy, systemic vasculitis, and renal vein thrombosis. [24] [25] Other infections have also been implicated as a cause of nephropathy, especially leptospirosis. [26] [27]", "contents": "Analgesic Nephropathy -- Differential Diagnosis. Several differentials require exclusion\u00a0while considering this diagnosis. As the common pathology in almost all patients with analgesic nephropathy\u00a0is papillary necrosis, other common conditions\u00a0can mimic this as well. These conditions include diabetes mellitus associated nephropathy, sickle cell disease with a renal crisis, obstructive uropathy, pyelonephritis, tuberculosis of the renal tract, alcohol\u00a0use induced nephropathy, systemic vasculitis, and renal vein thrombosis. [24] [25] Other infections have also been implicated as a cause of nephropathy, especially leptospirosis. [26] [27]"}
{"id": "article-17511_18", "title": "Analgesic Nephropathy -- Prognosis", "content": "As mentioned in earlier sections,\u00a0the presentation and prognosis of analgesia-induced nephropathy are variable and unpredictable.\u00a0Clinicians may expect to regain normal kidney function in most patients who present early in the course of renal involvement. A few individuals will progress to end-stage renal disease and dialysis even after stopping the drug if there is established\u00a0damage to the renal parenchyma and scarring of the renal tissue.", "contents": "Analgesic Nephropathy -- Prognosis. As mentioned in earlier sections,\u00a0the presentation and prognosis of analgesia-induced nephropathy are variable and unpredictable.\u00a0Clinicians may expect to regain normal kidney function in most patients who present early in the course of renal involvement. A few individuals will progress to end-stage renal disease and dialysis even after stopping the drug if there is established\u00a0damage to the renal parenchyma and scarring of the renal tissue."}
{"id": "article-17511_19", "title": "Analgesic Nephropathy -- Complications", "content": "End-stage\u00a0renal disease and related complications can be the expected sequelae of analgesic nephropathy, but it primarily depends on the extent of damage and duration of the disease.", "contents": "Analgesic Nephropathy -- Complications. End-stage\u00a0renal disease and related complications can be the expected sequelae of analgesic nephropathy, but it primarily depends on the extent of damage and duration of the disease."}
{"id": "article-17511_20", "title": "Analgesic Nephropathy -- Deterrence and Patient Education", "content": "Many studies have revealed that the most critical point of patient education is avoiding long-term analgesic use in preventing nephropathy. In some countries, decreasing media promotion or commercials for over-the-counter analgesics has shown effectiveness as a prevention strategy. Lastly, a collective effort is necessary for educating the general masses and patients about this preventable cause of renal disease.", "contents": "Analgesic Nephropathy -- Deterrence and Patient Education. Many studies have revealed that the most critical point of patient education is avoiding long-term analgesic use in preventing nephropathy. In some countries, decreasing media promotion or commercials for over-the-counter analgesics has shown effectiveness as a prevention strategy. Lastly, a collective effort is necessary for educating the general masses and patients about this preventable cause of renal disease."}
{"id": "article-17511_21", "title": "Analgesic Nephropathy -- Enhancing Healthcare Team Outcomes", "content": "The only possibility\u00a0of substantially improving the outcome of analgesia-induced nephropathy lies in its prevention. This will require the effort of an interprofessional team, including primary care providers, nephrologists, nurses, and pharmacists, to coordinate patient care. Studies have shown a\u00a0significant decrease in the incidence and prevalence of this disease as compared to the previous decades due to improved patient education and awareness. Clinicians, pharmacists, nurses, and all health care professionals\u00a0should emphasize the detrimental effects of long-term analgesia usage.", "contents": "Analgesic Nephropathy -- Enhancing Healthcare Team Outcomes. The only possibility\u00a0of substantially improving the outcome of analgesia-induced nephropathy lies in its prevention. This will require the effort of an interprofessional team, including primary care providers, nephrologists, nurses, and pharmacists, to coordinate patient care. Studies have shown a\u00a0significant decrease in the incidence and prevalence of this disease as compared to the previous decades due to improved patient education and awareness. Clinicians, pharmacists, nurses, and all health care professionals\u00a0should emphasize the detrimental effects of long-term analgesia usage."}
{"id": "article-17511_22", "title": "Analgesic Nephropathy -- Enhancing Healthcare Team Outcomes", "content": "The best care of analgesic nephropathy is avoiding the risk. An interprofessional approach can provide a multifaceted strategy to decrease this risk. Pharmacists dispensing the medications should counsel patients about the long-term risk of continued analgesic use and guide dosing. If they identify a patient at particular risk, they should contact the health care provider to encourage alternative forms of pain relief. Nurses often provide the initial evaluation of a patient's medications. In doing so, they can identify patients who are using excessive analgesics. The nurse should educate the patient and discuss their concerns with the healthcare team so that a plan of action can be initiated to assist the patient in reducing analgesic use. Only by approaching the education and treatment of a patient at risk through an interprofessional team will outcomes be improved. [Level 5]", "contents": "Analgesic Nephropathy -- Enhancing Healthcare Team Outcomes. The best care of analgesic nephropathy is avoiding the risk. An interprofessional approach can provide a multifaceted strategy to decrease this risk. Pharmacists dispensing the medications should counsel patients about the long-term risk of continued analgesic use and guide dosing. If they identify a patient at particular risk, they should contact the health care provider to encourage alternative forms of pain relief. Nurses often provide the initial evaluation of a patient's medications. In doing so, they can identify patients who are using excessive analgesics. The nurse should educate the patient and discuss their concerns with the healthcare team so that a plan of action can be initiated to assist the patient in reducing analgesic use. Only by approaching the education and treatment of a patient at risk through an interprofessional team will outcomes be improved. [Level 5]"}
{"id": "article-17511_23", "title": "Analgesic Nephropathy -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Analgesic Nephropathy -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}